Mobia Medical (NASDAQ:MOBI) was initiated with a ‘Buy’ rating and a $16 price target by Bank of America, which cited the ...
The estimated 1-year rate of ischemic stroke after implantation of the Watchman left atrial appendage (LAA) closure device (Boston Scientific) was 1.53% in its first few years of commercial use in the ...
MIAMI, July 09, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NSPR), developer of the CGuard Prime carotid stent system for the prevention of stroke, today announced the official commercial launch of the ...